Aquilon Pharma
Aquilon Pharma aims to play a disruptive role in next-generation formulation technology for inhaled medication by improving drug efficacy. With scientific roots in Liège University, the independent PharmaTech company specializes in improving the efficacy of drugs administered through inhalation. The company focuses on asthma, COPD, and nasal formulations compatible with all devices.
Key People
Paul Maes - CEO